Omron (OTCMKTS:OMRNY) Stock Price Up 23.7% – Time to Buy?

Omron Corp. (OTCMKTS:OMRNY) was up 23.7% during trading on Monday . The company traded as high as $31.51 and last traded at $31.51. Approximately 1,303 shares were traded during trading, a decline of 97% from the average daily volume of 45,504 shares. The stock had previously closed at $25.4750.

Analysts Set New Price Targets

Separately, Zacks Research raised shares of Omron from a “strong sell” rating to a “hold” rating in a report on Monday, January 19th. One research analyst has rated the stock with a Hold rating, Based on data from MarketBeat.com, the stock currently has an average rating of “Hold”.

Omron Stock Performance

The company has a debt-to-equity ratio of 0.13, a current ratio of 2.14 and a quick ratio of 1.40. The firm has a market cap of $6.56 billion, a price-to-earnings ratio of 40.27, a P/E/G ratio of 0.47 and a beta of 0.98. The firm has a fifty day simple moving average of $25.62 and a two-hundred day simple moving average of $26.39.

Omron (OTCMKTS:OMRNY) last announced its quarterly earnings data on Thursday, February 5th. The company reported $0.17 earnings per share for the quarter, missing analysts’ consensus estimates of $0.36 by ($0.19). The company had revenue of $1.41 billion for the quarter, compared to analysts’ expectations of $1.38 billion. Omron had a net margin of 2.80% and a return on equity of 2.46%. Omron has set its FY 2025 guidance at 0.960-0.960 EPS. On average, analysts expect that Omron Corp. will post 0.42 EPS for the current year.

Institutional Inflows and Outflows

A hedge fund recently raised its stake in Omron stock. GAMMA Investing LLC boosted its stake in shares of Omron Corp. (OTCMKTS:OMRNY) by 50.7% during the 4th quarter, according to its most recent filing with the SEC. The firm owned 2,129 shares of the company’s stock after purchasing an additional 716 shares during the period. GAMMA Investing LLC’s holdings in Omron were worth $54,000 at the end of the most recent quarter. 1.09% of the stock is owned by hedge funds and other institutional investors.

About Omron

Omron Corporation (OTCMKTS: OMRNY) is a global leader in automation, sensing, and control technologies. The company designs, manufactures, and sells a wide range of products and solutions for industrial, healthcare and social systems applications. Its core business segments include industrial automation—featuring programmable logic controllers, sensors, relays, servo motors and temperature controllers—and healthcare products such as blood pressure monitors, digital thermometers and nebulizers.

Founded in 1933 by Kazuma Tateishi in Kyoto, Japan, Omron began with the development of the first Japanese automatic timer.